Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan
- PMID: 27714496
- PMCID: PMC5306182
- DOI: 10.1007/s11262-016-1396-9
Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan
Abstract
We report five cases of community- and hospital-acquired infections with oseltamivir- and peramivir-resistant A(H1N1)pdm09 viruses possessing the neuraminidase (NA) H275Y mutation during January-February 2016 in Japan. One case was hospitalized and was receiving oseltamivir for prophylaxis. The remaining four cases were not taking antiviral drugs at the time of sampling. These cases were geographically distant and epidemiologically unrelated. The five viruses showed ~300-fold rise in IC50 values against oseltamivir and peramivir, defined as highly reduced inhibition according to the WHO definition. Overall, the prevalence of the H275Y A(H1N1)pdm09 viruses was 1.8 % (5/282). The resistant viruses possessed the V241I, N369 K, and N386 K substitutions in the NA that have been previously reported among A(H1N1)pdm09 to alter transmission fitness. Analysis of Michaelis constant (Km) revealed that two of the isolates had reduced NA affinity to MUNANA, while the other three isolates displayed a slightly decreased affinity compared to the sensitive viruses. Further studies are needed to monitor the community spread of resistant viruses and to assess their transmissibility.
Keywords: Antiviral drug susceptibility; Community transmission; Enzymatic property; Influenza virus A(H1N1)pdm09; Neuraminidase; Oseltamivir resistant.
Conflict of interest statement
Compliance with Ethical Standards Conflict of Interest: Reiko Saito received research grants from Shionogi Co., Ltd. Other authors, Akinobu Hibino, Hiroki Kondo, Hironori Masaki, Yoshinari Tanabe, Isamu Sato, Nobuhiro Takemae, Takehiko Saito, and Hassan Zaraket, declare that they have no conflict of interest. Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Niigata University Ethics Committee (H23-1178). Informed consent Informed consent was obtained from all individual participants included in the study.
Figures
Similar articles
-
Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.Influenza Other Respir Viruses. 2013 Nov;7(6):1390-9. doi: 10.1111/irv.12132. Epub 2013 Jun 8. Influenza Other Respir Viruses. 2013. PMID: 23745712 Free PMC article.
-
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.J Infect Dis. 2012 Jul 15;206(2):148-57. doi: 10.1093/infdis/jis337. Epub 2012 May 4. J Infect Dis. 2012. PMID: 22561367 Free PMC article.
-
Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.Virol J. 2015 Jun 24;12:96. doi: 10.1186/s12985-015-0317-1. Virol J. 2015. PMID: 26103966 Free PMC article.
-
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1(Suppl 1):25-36. doi: 10.1111/irv.12047. Influenza Other Respir Viruses. 2013. PMID: 23279894 Free PMC article. Review.
-
The epidemiology and spread of drug resistant human influenza viruses.Curr Opin Virol. 2014 Oct;8:22-9. doi: 10.1016/j.coviro.2014.04.009. Epub 2014 May 24. Curr Opin Virol. 2014. PMID: 24866471 Review.
Cited by
-
Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.PLoS One. 2019 Nov 7;14(11):e0224683. doi: 10.1371/journal.pone.0224683. eCollection 2019. PLoS One. 2019. PMID: 31697721 Free PMC article.
-
Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza.Clin Transl Sci. 2020 Jan;13(1):157-168. doi: 10.1111/cts.12697. Epub 2019 Nov 7. Clin Transl Sci. 2020. PMID: 31664778 Free PMC article.
-
Aloe Polysaccharides Inhibit Influenza A Virus Infection-A Promising Natural Anti-flu Drug.Front Microbiol. 2018 Sep 27;9:2338. doi: 10.3389/fmicb.2018.02338. eCollection 2018. Front Microbiol. 2018. PMID: 30319596 Free PMC article.
References
-
- World Health Organization Wkly Epidemiol. Rec. 2012;87:369–374. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
